A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 601-609

  Yonemura, Yutaka ^a   Fujimura, Takashi ^a   Fushida, Sachio ^a   Fujita, Hideto ^a   Bando, Etsurou ^a   Nishimura, Genichi ^a   Miwa, Kouichi ^b   Endou, Yoshio ^a   Tanaka, Motohiro ^a   Sasaki, Takuma ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Gastric cancer; Hyperthermia; Peritoneal dissemination; Peritonectomy

Indexed keywords

CISPLATIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; SODIUM CHLORIDE; URACIL;

ABDOMINAL WALL; ARTICLE; CHEMOTHERAPY; DIAPHRAGM; HUMAN; HYPERTHERMIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PELVIS; PERFUSION; PERITONEAL CAVITY; PERITONEAL DISEASE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH PARIETAL CELL; SURGICAL APPROACH; SURVIVAL RATE; TEMPERATURE MEASUREMENT; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; PERITONEAL NEOPLASMS; PERITONEUM; STOMACH NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033056112     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 1 Hagiwara A, Takahashi T, Kojima O, Sawai K, Yamaguchi T, Yamane T, Taniguchi H, Kitamura K, Noguchi A, Seiki K, Sakakura G: Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 1992; 339:629-631.
2. 2 Koga S, Izumi A, Maeta M, Shimizu N, Osaki Y, Kanayama H: The effects of total-body hyperthermia combined with anticancer drugs on immunity in advanced cancer patients. Cancer 1983; 52:1173-1177.
3. 3 Markman M: Intraperitoneal chemotherapy. Seminars in Oncol 1991; 18:248-254.
4. 4 Brenner DE: Intraperitoneal chemotherapy: a review. J Clin Oncol 1986; 4:1135-1147.
5. 5 Los G, Mutsaers PHA, van der Vijgh WJF, Badlew GS, de Graaf PW, McVie JG: Direct diffusion of cis-diamminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 1989; 49:3380-3384.
6. 6 Averbach AM, Sugarbaker PH: Methodologic considerations in treatment using intraperitoneal chemotherapy. In: Sugarbaker PH (Ed.). Peritoneal Carcinomatosis: Principles of Management. Boston/Dordorecht/London: Klugar Academic Publishers, 1996; pp. 289-309.
7. 7 Yonemura Y: Mechanisms of drug resistance in gastric cancer. In: Yonemura Y (Ed.). Contemporary approaches toward cure of gastric cancer. Kanazawa: Maeda Shoten Co., Ltd., 1996; pp. 87-92.
8. 8 Sugarbaker PH: Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer. In: Sugarbaker PH (Ed.). Peritoneal Carcinomatosis: Principles of Management. Boston/Dordorecht/London: Klugar Academic Publishers, 1996; pp. 75-87.
9. 9 Yonemura Y: Surgical techniques for subtotal peritonectomy. In: Yonemura Y (Ed.). Contemporary approaches toward cure of gastric cancer. Kanazawa: Maeda Shoten Co., Ltd., 1996; pp. 163-176.
10. 10 Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, Tsugawa K, Fushida S, Miyazaki I, Tanaka M, Endou Y, Sasaki T: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996; 119:437-444.
11. 11 Yonemura Y, Sawa T, Kinoshita K, Matsuki N, Fushida S, Tanaka S, Ohoyama S, Takashima T, Kimura H, Kamata T, Fujimura T, Sugiyama K, Shima K, Miyazaki I: Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 1993; 17:256-263.
12. 12 Yonemura Y: D2-gastrectomy. In: Yonemura Y (Ed.). Contemporary approaches toward cure of gastric cancer. Kanazawa: Maeda Shoten Co., Ltd., 1996; pp. 139-146.
13. 13 Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (Ed.). Peritoneal Carcinomatosis: Principles of Management. Boston/Dordorecht/London: Klugar Academic Publishers, 1996; pp. 359-374.
14. 14 Wilke H, Preussor P, Fink U, Achterrath W, Meyer HJ, Stall M, Leans L, Meyer J, Siewert JR, Greerlings H, Kohne-Wompner CH, Harstrick A, Schmoll HJ: New development in the treatment of gastric cancer. Seminars in Oncol 1990; 17:61-70.
15. 15 Sugarbaker PH, Stuart A, Vidal-Jove J, Pessagno AM, Debruijin EA: Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration. In: Sugarbaker PH (Ed.). Peritoneal Carcinomatosis: Principles of Management. Boston/Dordorecht/London: Klugar Academic Publishers, 1996; pp. 41-51.
16. 16 Jain RK: Barriers to drug delivery in solid tumor. Scientific Amer 1994; 7:42-49.
17. 17 Hiratsuka M, Ogawa A, Oohigashi A, Kameyama M, Sasaki H, Ishikawa O, Kabuto T, Fukuda I, Furukawa H, Iomaoka M, Koyama H, Iwanaga T: Dosage and its safety on intraperitoneal high dose mitomycin C administration as postoperative adjuvant therapy for gastric cancer. J Jpn Soc Cancer Ther 1988; 23:1574-1579.
18. 18 Giovanella BC: Selective lethal effect of supranormal temperatures on mouse sarcoma cells. Cancer Res 1973; 33:2568-2578.
19. 19 Los G, van Vugt MJH, Pinedo HM: Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994; 69:235-241.
20. 20 Hettinga JVE, Lemstra W, Meijer C, Dam WA, Uges WA, Konings AWT, De Vries EGE, Kampinga HH: Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumor cells. Br J Cancer 1997; 75:1735-1743.